The relationship between study design, results, and reporting of randomized clinical trials of HIV infection

scientific article published on October 1, 1997

The relationship between study design, results, and reporting of randomized clinical trials of HIV infection is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1016/S0197-2456(97)00097-4
P8608Fatcat IDrelease_qvdohylq7nempmkgszx4lefive
P953full work available at URLhttps://api.elsevier.com/content/article/PII:S0197245697000974?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:S0197245697000974?httpAccept=text/xml
P698PubMed publication ID9315426

P50authorJohn IoannidisQ6251482
P2093author name stringJ. Lau
H. S. Sacks
J. P. Ioannidis
J. C. Cappelleri
P2860cites workEmpirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsQ27860735
Publication bias and clinical trialsQ34179248
NIH clinical trials and publication biasQ34349425
The existence of publication bias and risk factors for its occurrenceQ34373168
The statistical basis of meta-analysisQ40790809
Surrogate end points in clinical trials: are we being misled?Q41117631
Misleading meta-analysisQ42841765
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.Q44192276
Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illnessQ49255435
An analysis of variance test for normality (complete samples)Q57253423
An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trialsQ68075886
Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversionQ72624142
Surrogate markers in AIDS and cancer trialsQ72838283
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)431-444
P577publication date1997-10-01
P1433published inContemporary Clinical TrialsQ5164971
P1476titleThe relationship between study design, results, and reporting of randomized clinical trials of HIV infection
P478volume18

Reverse relations

cites work (P2860)
Q24288921Association of trial registration with the results and conclusions of published trials of new oncology drugs
Q36035572Automated cognome construction and semi-automated hypothesis generation
Q47324266Effects of dietary weight loss on obstructive sleep apnea: a meta-analysis.
Q36966424Evaluation of networks of randomized trials
Q36735944Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials
Q24288780Evolution and translation of research findings: from bench to where?
Q21563421Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others
Q28475588Factors associated with results and conclusions of trials of thiazolidinediones
Q36637482Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses
Q37329334Interpretation of tests of heterogeneity and bias in meta-analysis
Q35177554Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study
Q52899891Meta-Analyses and Large Randomized, Controlled Trials
Q33833322Publication bias in reproductive medicine: from the European Society of Human Reproduction and Embryology annual meeting to publication
Q21203744Reporting bias in medical research - a narrative review
Q77664569Reporting of safety data from randomised trials
Q44081925Substantial evidence of effect
Q37641067The use of older studies in meta-analyses of medical interventions: a survey.
Q31083105Treatment outcomes after highly active antiretroviral therapy: a meta-analysis of randomised controlled trials

Search more.